Johnson & Johnson Price to Book Ratio 2010-2022 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of February 03, 2023 is 5.80.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-02-03 164.61 5.77
2022-09-30 162.32 $28.51 5.69
2022-06-30 175.20 $29.04 6.03
2022-03-31 173.83 $28.41 6.12
2021-12-31 166.70 $28.16 5.92
2021-09-30 156.34 $26.69 5.86
2021-06-30 158.53 $26.44 6.00
2021-03-31 157.18 $25.01 6.29
2020-12-31 149.58 $24.04 6.22
2020-09-30 140.51 $24.49 5.74
2020-06-30 131.85 $23.92 5.51
2020-03-31 122.09 $23.28 5.24
2019-12-31 134.94 $22.59 5.97
2019-09-30 118.86 $22.13 5.37
2019-06-30 127.95 $23.01 5.56
2019-03-31 127.55 $22.20 5.75
2018-12-31 116.98 $22.44 5.21
2018-09-30 124.45 $24.09 5.17
2018-06-30 108.57 $23.45 4.63
2018-03-31 113.82 $23.58 4.83
2017-12-31 123.31 $22.43 5.50
2017-09-30 114.05 $27.55 4.14
2017-06-30 115.31 $26.78 4.31
2017-03-31 107.85 $26.10 4.13
2016-12-31 99.12 $26.02 3.81
2016-09-30 100.93 $26.73 3.78
2016-06-30 102.95 $26.47 3.89
2016-03-31 91.19 $26.40 3.45
2015-12-31 85.95 $25.82 3.33
2015-09-30 77.54 $25.86 3.00
2015-06-30 80.33 $25.69 3.13
2015-03-31 82.31 $24.45 3.37
2014-12-31 84.97 $25.06 3.39
2014-09-30 86.05 $27.31 3.15
2014-06-30 83.89 $27.65 3.03
2014-03-31 78.22 $27.08 2.89
2013-12-31 72.41 $26.25 2.76
2013-09-30 68.07 $24.75 2.75
2013-06-30 66.92 $24.75 2.70
2013-03-31 63.06 $23.85 2.64
2012-12-31 53.79 $23.33 2.31
2012-09-30 52.42 $23.08 2.27
2012-06-30 50.93 $21.97 2.32
2012-03-31 49.25 $22.35 2.20
2011-12-31 48.54 $20.95 2.32
2011-09-30 46.70 $22.52 2.07
2011-06-30 48.35 $22.67 2.13
2011-03-31 42.70 $21.86 1.95
2010-12-31 44.17 $20.66 2.14
2010-09-30 43.87 $20.85 2.10
2010-06-30 41.43 $19.19 2.16
2010-03-31 45.32 $19.19 2.36
2009-12-31 44.43 $18.37 2.42
2009-09-30 41.67 $18.27 2.28
2009-06-30 38.56 $16.79 2.30
2009-03-31 35.40 $15.87 2.23
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $432.802B $94.943B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $314.224B 41.65
Novo Nordisk (NVO) Denmark $299.481B 38.14
Merck (MRK) United States $262.312B 13.83
AbbVie (ABBV) United States $256.147B 10.62
Pfizer (PFE) United States $248.894B 6.74
Novartis AG (NVS) Switzerland $190.505B 14.09